| 王怀璋,林焯唐.抗癌宝口服液治疗中晚期恶性肿瘤103例临床观察[J].,1997,(12):730-732 |
| 抗癌宝口服液治疗中晚期恶性肿瘤103例临床观察 |
| Clinical Study on Effect of Kang’aibao Oral Liquid in Treating 103 Malignant Tunmor Patients |
| |
| DOI： |
| 中文关键词: 中晚期恶性肿瘤 抗癌宝口服液 生存时间 生存质量 |
| 英文关键词:malignant tumor of middle or advanced stage Kangaibao oral liquid survival time quality of survival |
| 基金项目: |
|
| Hits: 1467 |
| Download times: 1071 |
| 中文摘要: |
| 目的：观察中药抗癌宝口服液（简称抗癌宝）治疗中晚期恶性肿瘤临床效果。方法：１０３例患者随机分为抗癌宝观察组与化疗对照组，对两组疗效作比较。结果：观察组患者免疫功能，近期有效率（ＣＲ＋ＰＲ），生存质量，１、２、３年生存期及中位生存时间，癌胚抗原下降水平，明显高于对照组，且有显著性差异。结论：抗癌宝具有抑制肿瘤生长，延长生存时间，提高生存质量之效。 |
| 英文摘要: |
| Objective: To observe the clinical efficacy of Kangaihao oral liquid(KABOL), a Chinese herbal Preparation in treating malignant turmor of middle or advanced stage. Methods:A comparative study was done by observing the effect of 103 patients treated with KABOL, and another 90 patients treated with chemotherapy in the same period were taken as a control group for comparison. Results : The immunologic function, short-term effective rate(complete relieved rate and partial relieved rate), survival quality, 1-, 2-and 3-year survival rate, median suvival time,and the CEA declining rate of the KABOL group were significantly higher than thine of the control group. Conclusions: KABOL has the effects of inhibiting tumor growth, prolonging the survival time and improving the quality ofsurvival of tumor patient. |
| View Full Text View/Add Comment Download reader |
